Update on left atrial appendage closure for neurologists
Authors:
- Karl Georg HaeuslerKHKarl Georg Haeusler
- Luciano A SposatoLSLuciano A Sposato
- Marek GrygierMGMarek Grygier
- Tatjana PotparaTPTatjana Potpara
- Jens Erik Nielsen-KudskJNJens Erik Nielsen-Kudsk
- Lucas V A BoersmaLBLucas V A Boersma
- Gregory Y H LipGLGregory Y H Lip
- Renate B SchnabelRSRenate B Schnabel
- Pavel OsmancikPOPavel Osmancik
- Boris SchmidtBSBoris Schmidt
- Wolfram DöhnerWolfram Döhner
- Jan KovacJKJan Kovac
Open Access
- 28 December 2025
- journal article
- review article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (1)
Abstract
A significant proportion of patients with atrial fibrillation (AF) who need thromboembolic protection are not treated with or discontinue oral anticoagulation after its initiation. Undertreatment in clinical practice has not improved sufficiently despite the availability of direct oral anticoagulants, which are associated with less intracranial bleeding than vitamin K antagonists. Multiple reasons account for this phenomenon, including bleeding events or ischemic strokes while on anticoagulation, poor treatment adherence despite best educational attempts, or aversion to drug therapy. Percutaneous left atrial appendage (LAA) closure was introduced as an alternative to pharmacological therapy in AF patients in the early 2000s. Due to significant improvements in procedural safety over the years, left atrial appendage closure (LAAC), predominantly achieved through a percutaneous catheter-based device implantation approach, is increasingly favoured for preventing thromboembolic events in patients who cannot achieve effective anticoagulation or have a high hemorrhagic risk. This focused summary and update of a recently published practical guide, developed within guideline/guidance boundaries, provides a perspective of current evidence of potential indications, benefits, complications and limitations of LAAC for neurologists and stroke physicians who may consider this increasingly utilised therapy.Keywords
This publication has 111 references indexed in Scilit:
- Antithrombotic treatment after stroke due to intracerebral haemorrhageCochrane Database of Systematic Reviews, 2023
- Review of Late-Breaking Trials From CRT 2022Cardiovascular Revascularization Medicine, 2022
- Left atrial appendage closure in patients with intracranial hemorrhageJournal of Interventional Cardiac Electrophysiology, 2022
- Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial FibrillationJAMA, 2021
- Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation RegistryJournal of Neurology, 2021
- Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial FibrillationCurrent Cardiology Reports, 2020
- Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial FibrillationAnnals of Neurology, 2020
- Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial FibrillationThe American Journal of Cardiology, 2018
- Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac SurgeryJAMA, 2018
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA, 2014